U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts
Aethlon Medical, Inc.
20/20 Biolabs, Inc.
AIM ImmunoTech Inc. Common Stock
Co-Diagnostics, Inc.
Cumberland Pharmaceuticals Inc.
Aethlon Medical, Inc. AEMD | 0.00 | |
20/20 Biolabs, Inc. AIDX | 0.00 | |
AIM ImmunoTech Inc. Common Stock AIM | 0.00 | |
Co-Diagnostics, Inc. CODX | 0.00 | |
Cumberland Pharmaceuticals Inc. CPIX | 0.00 |
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/